AbbVie Inc. (ABBV)
undefined
undefined%
At close: undefined
180.43
0.34%
After-hours Jan 06, 2025, 07:43 PM EST

AbbVie Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Botox Cosmetic Revenue 671.00M 633.00M 718.00M 620.00M 685.00M 659.00M 642.00M 637.00M 695.00M 641.00M 626.00M 545.00M 584.00M 477.00M 493.00M 393.00M 226.00M 559.00M 60.00M 695.00M 780.00M 790.00M -58.00M 839.00M 108.00M 103.00M 100.00M 94.00M 81.00M 80.00M 78.00M 74.00M 73.00M 68.00M 62.00M 61.00M 55.00M 53.00M 56.00M 56.00M 56.00M 52.00M 88.00M 46.00M 44.00M 277.00M
Botox Cosmetic Revenue Growth +6.00% -11.84% +15.81% -9.49% +3.95% +2.65% +0.78% -8.35% +8.42% +2.40% +14.86% -6.68% +22.43% -3.25% +25.45% +73.89% -59.57% +831.67% -91.37% -10.90% -1.27% -1462.07% -106.91% +676.85% +4.85% +3.00% +6.38% +16.05% +1.25% +2.56% +5.41% +1.37% +7.35% +9.68% +1.64% +10.91% +3.77% -5.36% 0.00% 0.00% +7.69% -40.91% +91.30% +4.55% -84.12% n/a
Juvederm Collection Revenue 258.00M 297.00M 334.00M 321.00M 368.00M 355.00M 322.00M 352.00M 344.00M 410.00M 432.00M 354.00M 428.00M 321.00M 331.00M 274.00M 113.00M 1.23B n/a 1.26B 1.10B 1.02B n/a 972.00M 5.18B 4.71B 4.89B 4.70B 4.72B 4.12B 4.29B 4.06B 4.15B 3.58B 3.72B 3.65B 3.54B 3.11B 3.36B 3.25B 393.00M 380.00M 671.00M 323.00M 395.00M n/a
Juvederm Collection Revenue Growth -13.13% -11.08% +4.05% -12.77% +3.66% +10.25% -8.52% +2.33% -16.10% -5.09% +22.03% -17.29% +33.33% -3.02% +20.80% +142.48% -90.83% n/a n/a +14.38% +7.53% n/a n/a -81.25% +10.11% -3.74% +4.06% -0.32% +14.52% -4.05% +5.71% -2.15% +15.99% -3.77% +1.92% +3.11% +13.69% -7.49% +3.32% +728.24% +3.42% -43.37% +107.74% -18.23% n/a n/a
Other Aesthetics Revenue 310.00M 319.00M 319.00M 298.00M 331.00M 286.00M 323.00M 312.00M 332.00M 323.00M 349.00M 352.00M 422.00M 343.00M 318.00M 300.00M 142.00M 317.00M n/a 221.00M 169.00M 151.00M n/a 96.00M 850.00M 762.00M 708.00M 688.00M 626.00M 551.00M 511.00M 501.00M 439.00M 381.00M 343.00M 304.00M 107.00M 303.00M 486.00M 370.00M n/a n/a n/a n/a n/a n/a
Other Aesthetics Revenue Growth -2.82% 0.00% +7.05% -9.97% +15.73% -11.46% +3.53% -6.02% +2.79% -7.45% -0.85% -16.59% +23.03% +7.86% +6.00% +111.27% -55.21% n/a n/a +30.77% +11.92% n/a n/a -88.71% +11.55% +7.63% +2.91% +9.90% +13.61% +7.83% +2.00% +14.12% +15.22% +11.08% +12.83% +184.11% -64.69% -37.65% +31.35% n/a n/a n/a n/a n/a n/a n/a
Alphagan/Combigan Revenue 62.00M 59.00M 66.00M 70.00M 65.00M 71.00M 74.00M 73.00M 92.00M 107.00M 141.00M 128.00M 142.00M 118.00M 134.00M 123.00M 69.00M 4.70B n/a 4.94B 4.87B 4.45B n/a 5.12B 151.00M 201.00M 231.00M 181.00M 289.00M 297.00M 289.00M 342.00M 309.00M 277.00M 302.00M 310.00M 308.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Alphagan/Combigan Revenue Growth +5.08% -10.61% -5.71% +7.69% -8.45% -4.05% +1.37% -20.65% -14.02% -24.11% +10.16% -9.86% +20.34% -11.94% +8.94% +78.26% -98.53% n/a n/a +1.36% +9.54% n/a n/a +3293.38% -24.88% -12.99% +27.62% -37.37% -2.69% +2.77% -15.50% +10.68% +11.55% -8.28% -2.58% +0.65% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Lumigan/Ganfort Revenue 116.00M 91.00M 92.00M 91.00M 119.00M 130.00M 123.00M 121.00M 130.00M 140.00M 149.00M 138.00M 149.00M 143.00M 153.00M 149.00M 76.00M 86.00M n/a 91.00M 48.00M 111.00M n/a 106.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Lumigan/Ganfort Revenue Growth +27.47% -1.09% +1.10% -23.53% -8.46% +5.69% +1.65% -6.92% -7.14% -6.04% +7.97% -7.38% +4.20% -6.54% +2.68% +96.05% -11.63% n/a n/a +89.58% -56.76% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Eye Care Revenue 207.00M 200.00M 181.00M 207.00M 215.00M 200.00M 283.00M 287.00M 327.00M 278.00M 306.00M 286.00M 301.00M 276.00M 296.00M 269.00M 128.00M 300.00M n/a 117.00M 115.00M 114.00M n/a 25.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Eye Care Revenue Growth +3.50% +10.50% -12.56% -3.72% +7.50% -29.33% -1.39% -12.23% +17.63% -9.15% +6.99% -4.98% +9.06% -6.76% +10.04% +110.16% -57.33% n/a n/a +1.74% +0.88% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Ozurdex Revenue 119.00M 131.00M 118.00M 120.00M 119.00M 115.00M 110.00M 142.00M 168.00M 246.00M 364.00M 319.00M 327.00M 280.00M 344.00M 299.00M 144.00M 124.00M n/a 83.00M 254.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Ozurdex Revenue Growth -9.16% +11.02% -1.67% +0.84% +3.48% +4.55% -22.54% -15.48% -31.71% -32.42% +14.11% -2.45% +16.79% -18.60% +15.05% +107.64% +16.13% n/a n/a -67.32% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Restasis Revenue 21.00M 57.00M 128.00M 117.00M 99.00M 92.00M 1.11B 1.14B 1.15B 1.17B 1.39B 1.37B 1.38B 1.27B 2.66B 1.37B 1.29B 105.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Restasis Revenue Growth -63.16% -55.47% +9.40% +18.18% +7.61% -91.75% -1.76% -0.87% -2.39% -15.31% +0.80% -0.51% +8.91% -52.26% +93.87% +6.37% +1126.67% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Imbruvica Revenue 828.00M 838.00M 903.00M 908.00M 907.00M 878.00M 516.00M 515.00M 505.00M 473.00M 488.00M 492.00M 435.00M 405.00M 682.00M 352.00M 303.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Imbruvica Revenue Growth -1.19% -7.20% -0.55% +0.11% +3.30% +70.16% +0.19% +1.98% +6.77% -3.07% -0.81% +13.10% +7.41% -40.62% +93.75% +16.17% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
VENCLEXTA Revenue 677.00M 614.00M 589.00M 590.00M 571.00M 538.00M 5.58B 5.56B 5.36B 4.74B 5.33B 5.42B 5.07B 4.87B 9.86B 5.14B 4.84B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
VENCLEXTA Revenue Growth +10.26% +4.24% -0.17% +3.33% +6.13% -90.36% +0.36% +3.65% +13.24% -11.21% -1.68% +7.04% +4.13% -50.61% +91.73% +6.26% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
H U M I R A Revenue 2.23B 2.27B 3.30B 3.55B 4.01B 3.54B 770.00M 695.00M 592.00M 465.00M 517.00M 453.00M 378.00M 303.00M 367.00M 215.00M 149.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
H U M I R A Revenue Growth -1.89% -31.30% -6.85% -11.59% +13.30% +359.87% +10.79% +17.40% +27.31% -10.06% +14.13% +19.84% +24.75% -17.44% +70.70% +44.30% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
RINVOQ Revenue 1.61B 1.09B 1.25B 1.11B 918.00M 686.00M 1.58B 1.40B 1.25B 940.00M 895.00M 796.00M 674.00M 574.00M 825.00M 435.00M 330.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
RINVOQ Revenue Growth +47.67% -12.91% +13.06% +20.92% +33.82% -56.47% +12.81% +11.58% +33.19% +5.03% +12.44% +18.10% +17.42% -30.42% +89.66% +31.82% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
SKYRIZI Revenue 3.21B 2.01B 2.39B 2.13B 1.88B 1.36B 728.00M 699.00M 678.00M 614.00M 671.00M 645.00M 603.00M 532.00M 567.00M 523.00M 297.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
SKYRIZI Revenue Growth +59.61% -16.12% +12.61% +12.90% +38.46% +86.81% +4.15% +3.10% +10.42% -8.49% +4.03% +6.97% +13.35% -6.17% +8.41% +76.09% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Botox Therapeutic Revenue 848.00M 748.00M 776.00M 748.00M 748.00M 719.00M 107.00M 110.00M 120.00M 121.00M 128.00M 127.00M 127.00M 129.00M 253.00M 123.00M 118.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Botox Therapeutic Revenue Growth +13.37% -3.61% +3.74% 0.00% +4.03% +571.96% -2.73% -8.33% -0.83% -5.47% +0.79% 0.00% -1.55% -49.01% +105.69% +4.24% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Duodopa Revenue 111.00M 115.00M 115.00M 118.00M 117.00M 118.00M 61.00M 87.00M 150.00M 177.00M 183.00M 171.00M 171.00M 160.00M 227.00M 207.00M 105.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Duodopa Revenue Growth -3.48% 0.00% -2.54% +0.85% -0.85% +93.44% -29.89% -42.00% -15.25% -3.28% +7.02% 0.00% +6.88% -29.52% +9.66% +97.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Neuroscience Revenue 84.00M 74.00M 66.00M 61.00M 70.00M 79.00M 269.00M 271.00M 255.00M 240.00M 287.00M 261.00M 268.00M 222.00M 286.00M 248.00M 133.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Neuroscience Revenue Growth +13.51% +12.12% +8.20% -12.86% -11.39% -70.63% -0.74% +6.27% +6.25% -16.38% +9.96% -2.61% +20.72% -22.38% +15.32% +86.47% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Qulipta Revenue 176.00M 131.00M 180.00M 132.00M 96.00M 152.00M 380.00M 383.00M 398.00M 380.00M 427.00M 426.00M 442.00M 415.00M 1.04B 414.00M 376.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Qulipta Revenue Growth +34.35% -27.22% +36.36% +37.50% -36.84% -60.00% -0.78% -3.77% +4.74% -11.01% +0.23% -3.62% +6.51% -60.10% +151.21% +10.11% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Ubrelvy Revenue 269.00M 203.00M 234.00M 233.00M 196.00M 561.00M 992.00M 925.00M 1.01B 1.21B 594.00M 547.00M 640.00M 892.00M 1.40B 829.00M 590.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Ubrelvy Revenue Growth +32.51% -13.25% +0.43% +18.88% -65.06% -43.45% +7.24% -8.33% -16.68% +103.87% +8.59% -14.53% -28.25% -36.24% +68.76% +40.51% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Vraylar Revenue 875.00M 694.00M 789.00M 751.00M 658.00M 259.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Vraylar Revenue Growth +26.08% -12.04% +5.06% +14.13% +154.05% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Linzess/Constella Revenue 234.00M 266.00M 283.00M 288.00M 278.00M 364.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Linzess/Constella Revenue Growth -12.03% -6.01% -1.74% +3.60% -23.63% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
MAVYRET Revenue 302.00M 349.00M 309.00M 370.00M 387.00M 691.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
MAVYRET Revenue Growth -13.47% +12.94% -16.49% -4.39% -43.99% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Products Revenue 726.00M 744.00M 821.00M 782.00M 741.00M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Products Revenue Growth -2.42% -9.38% +4.99% +5.53% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013
Australia Revenue 472.00M 508.00M 533.00M 527.00M 359.00M 350.00M 410.00M 355.00M 4.00B 3.27B 439.00M
Australia Revenue Growth -7.09% -4.69% +1.14% +46.80% +2.57% -14.63% +15.49% -91.13% +22.28% +645.33% n/a
Brazil Revenue 439.00M 430.00M 368.00M 406.00M 813.00M 730.00M 659.00M 624.00M n/a n/a 538.00M
Brazil Revenue Growth +2.09% +16.85% -9.36% -50.06% +11.37% +10.77% +5.61% n/a n/a n/a n/a
Canada Revenue 1.08B 1.16B 1.40B 1.16B 695.00M 783.00M 730.00M 713.00M n/a n/a 540.00M
Canada Revenue Growth -7.16% -17.04% +20.53% +66.76% -11.24% +7.26% +2.38% n/a n/a n/a n/a
China Revenue 950.00M 912.00M 857.00M 471.00M 909.00M 1.29B 1.16B 1.10B n/a n/a 911.00M
China Revenue Growth +4.17% +6.42% +81.95% -48.18% -29.64% +11.67% +4.80% n/a n/a n/a n/a
France Revenue 780.00M 787.00M 936.00M 797.00M 372.00M 652.00M 475.00M 523.00M n/a n/a 404.00M
France Revenue Growth -0.89% -15.92% +17.44% +114.25% -42.94% +37.26% -9.18% n/a n/a n/a n/a
Germany Revenue 1.27B 1.34B 1.22B 1.05B 1.21B 1.59B 764.00M 770.00M n/a n/a 625.00M
Germany Revenue Growth -5.52% +9.57% +16.59% -13.38% -23.88% +108.25% -0.78% n/a n/a n/a n/a
Italy Revenue 484.00M 444.00M 506.00M 379.00M 3.99B 4.01B 4.08B 3.88B n/a n/a 3.15B
Italy Revenue Growth +9.01% -12.25% +33.51% -90.51% -0.50% -1.64% +5.02% n/a n/a n/a n/a
Japan Revenue 1.01B 956.00M 1.09B 1.20B 472.00M 611.00M 521.00M 589.00M n/a n/a 543.00M
Japan Revenue Growth +5.44% -12.29% -9.02% +153.81% -22.75% +17.27% -11.54% n/a n/a n/a n/a
Other Countries Revenue 5.04B 4.84B 4.76B 3.98B n/a n/a 18.25B 15.95B n/a n/a 10.18B
Other Countries Revenue Growth +4.24% +1.60% +19.71% n/a n/a n/a +14.45% n/a n/a n/a n/a
Spain Revenue 501.00M 506.00M 519.00M 453.00M n/a n/a n/a n/a n/a n/a n/a
Spain Revenue Growth -0.99% -2.50% +14.57% n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 41.88B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 4.21B 3.34B 3.30B 3.61B 3.37B 3.27B 3.04B 3.42B 3.30B 5.41B 3.13B 3.26B 3.08B 3.16B 2.84B 3.23B 2.85B 3.53B 1.70B 1.95B 1.66B 1.65B 1.68B 1.93B 1.92B 1.76B 1.79B 1.95B 1.45B 1.50B 1.37B 1.65B 1.38B 1.47B 1.35B 1.74B 1.47B 1.70B 1.47B
Selling, General, and Administrative Revenue Growth +25.82% +1.27% -8.49% +6.94% +3.18% +7.54% -11.06% +3.42% -38.95% +73.07% -4.08% +5.74% -2.56% +11.33% -12.04% +13.53% -19.31% +108.08% -13.12% +17.74% +0.18% -1.55% -12.91% +0.52% +9.03% -1.73% -8.20% +34.37% -3.46% +9.94% -17.24% +19.70% -5.80% +8.19% -21.99% +17.84% -13.45% +15.61% n/a
Research and Development Revenue 2.13B 1.92B 1.94B 1.92B 1.72B 1.73B 2.29B 1.79B 1.61B 1.61B 1.50B 1.83B 1.67B 1.80B 1.78B 1.89B 1.71B 1.58B 1.38B 1.54B 2.29B 1.29B 1.29B 6.50B 1.27B 1.32B 1.24B 1.40B 1.22B 1.22B 1.14B 1.19B 1.11B 1.12B 946.00M 1.07B 1.42B 981.00M 811.00M
Research and Development Revenue Growth +11.11% -1.13% +0.94% +11.49% -0.58% -24.39% +28.04% +10.90% +0.31% +7.48% -18.06% +9.21% -7.16% +1.12% -5.71% +10.79% +7.84% +14.72% -10.57% -32.52% +76.99% +0.16% -80.15% +412.22% -4.08% +6.27% -11.27% +14.73% -0.08% +7.75% -4.62% +7.59% -1.60% +18.82% -12.00% -24.19% +44.55% +20.96% n/a

Create Price Alert on ABBV

Your price alert will notify you when the stock price is above 179.81.

Add to Watchlist